Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $6.
Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $6.